Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.43 - $5.9 $8,132 - $111,586
18,913 Added 0.93%
2,046,749 $1.18 Million
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.64 $677,644 - $1.14 Million
-1,783,275 Reduced 46.79%
2,027,836 $969,000
Q1 2022

May 13, 2022

SELL
$0.55 - $0.98 $21,533 - $38,368
-39,152 Reduced 1.02%
3,811,111 $2.55 Million
Q4 2021

Feb 11, 2022

SELL
$0.9 - $1.31 $20,866 - $30,372
-23,185 Reduced 0.6%
3,850,263 $3.8 Million
Q3 2021

Nov 12, 2021

BUY
$1.21 - $1.61 $152,716 - $203,201
126,212 Added 3.37%
3,873,448 $4.96 Million
Q2 2021

Aug 13, 2021

BUY
$1.6 - $2.02 $332,896 - $420,281
208,060 Added 5.88%
3,747,236 $6.11 Million
Q1 2021

May 12, 2021

BUY
$1.86 - $2.87 $967,880 - $1.49 Million
520,366 Added 17.24%
3,539,176 $7.01 Million
Q4 2020

Feb 12, 2021

BUY
$1.65 - $2.43 $105,177 - $154,897
63,744 Added 2.16%
3,018,810 $6.25 Million
Q3 2020

Nov 13, 2020

BUY
$1.6 - $2.35 $106,876 - $156,975
66,798 Added 2.31%
2,955,066 $5.05 Million
Q2 2020

Aug 13, 2020

BUY
$1.33 - $2.76 $1.64 Million - $3.41 Million
1,235,143 Added 74.72%
2,888,268 $6.7 Million
Q1 2020

May 14, 2020

BUY
$0.97 - $2.85 $128,083 - $376,328
132,045 Added 8.68%
1,653,125 $2.56 Million
Q4 2019

Feb 13, 2020

BUY
$1.69 - $3.8 $103,860 - $233,532
61,456 Added 4.21%
1,521,080 $5.78 Million
Q3 2019

Nov 12, 2019

BUY
$0.61 - $2.21 $188,840 - $684,160
309,575 Added 26.92%
1,459,624 $2.69 Million
Q2 2019

Aug 14, 2019

SELL
$0.51 - $0.86 $305,560 - $515,259
-599,139 Reduced 34.25%
1,150,049 $749,000
Q1 2019

May 14, 2019

BUY
$0.51 - $0.82 $24,893 - $40,025
48,811 Added 2.87%
1,749,188 $1.09 Million
Q4 2018

Feb 13, 2019

BUY
$0.48 - $1.1 $32,767 - $75,092
68,266 Added 4.18%
1,700,377 $821,000
Q3 2018

Nov 13, 2018

SELL
$1.06 - $1.69 $17,769 - $28,331
-16,764 Reduced 1.02%
1,632,111 $1.8 Million
Q2 2018

Aug 14, 2018

BUY
$1.56 - $2.51 $422,708 - $680,127
270,967 Added 19.67%
1,648,875 $2.57 Million
Q1 2018

May 15, 2018

BUY
$0.91 - $2.24 $189,090 - $465,454
207,792 Added 17.76%
1,377,908 $2.95 Million
Q4 2017

Feb 13, 2018

BUY
$0.78 - $2.1 $30,337 - $81,677
38,894 Added 3.44%
1,170,116 $1.08 Million
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $152,543 - $179,115
98,415 Added 9.53%
1,131,222 $2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,032,807
1,032,807 $1.61 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $171M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.